J&J's Cordis hit with Class I recall; LDR wins FDA approval for spinal implant;

@FierceMedDev: Zimmer owes Stryker $228M in patent lawsuit. News | Follow @FierceMedDev

@DamianFierce: Meet Verizon Wireless, medical device manufacturer. Story | Follow @DamianFierce

@MichaelGFierce: GE, U. of Wash. team up to make paper-based diagnostics device. Article | Follow @MichaelGFierce

> Johnson & Johnson's ($JNJ) Cordis received the FDA's most-serious recall tag over a label update the company applied to its Optease retrievable vena cava filter. More

> CareFusion's ($CFN) revenue slid 6.1% to $903 million last quarter, but the company's net income rose 21% to $110 million. Results

> Austin's LDR won FDA approval for its Mobi-C spinal disc replacement. News

> The U.K.'s Endomagnetics hauled in $3.2 million in venture cash to expand its staff and market its cancer diagnostics technology. Article

> Boston Scientific ($BSX) is raising about $1 billion in senior notes. Item

> Insulet's ($PODD) second-quarter revenue jumped 18% to $60.1 million, and the company slashed its net loss by about 45% to $5.8 million. Results

> Quest Diagnostics ($DGX) has launched a genetic test designed to determine patients' response to opioid therapy, helping physicians determine the likelihood of effectiveness and odds of addiction development. Release

Biotech News

@FierceBiotech: Popular yesterday: Upsized Intrexon IPO delivers another blockbuster success for billionaire Kirk. Story | Follow @FierceBiotech

@JohnCFierce: Over the past month 7 biotechs have raised $562M from IPOs. Brings the year's total so far to more than $2B. | Follow @JohnCFierce

@RyanMFierce: Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug. News | Follow @RyanMFierce

@EmilyMFierce: NIH and Lacks family decision to open genomic data of HeLa cells to researchers will also establish genome database. Article | Follow @EmilyMFierce

> FDA deals Novo Nordisk another setback for hemophilia therapy. Report

> Is the biotech IPO frenzy headed for a crack-up? Editor's Corner

Pharma News

@FiercePharma: Allergan joins the patent-loss party in India: Board revokes patents on Ganfort, Combigan glaucoma meds. Report | Follow @FiercePharma

@EricPFierce: Onyx CEO insists there are multiple players at buyout poker table. Reports had said Amgen sat alone. Story | Follow @EricPFierce

@CarlyHFierce: Incredulity turns to praise as malaria vax posts positive PhI data. More from FierceVaccines | Follow @CarlyHFierce

> Dendreon's Provenge sales off again, expected to miss for the year. More

> Pharma professionals feeling angst, but see a few rays of hope. Article

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.